Status: Not yet recruiting
CYTALUX Dose Extension Study
The goal of this clinical trial is to learn whether giving Cytalux™ (pafolacianine) injection several days before surgery works as well as giving it closer to the time of surgery for helping surgeons see lesions during an operation. This study is being done in adult patients undergoing surgery for malignant or non-malignant lung lesions or for confirmed ovarian cancer.
Participants needed: 106
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: On Target Laboratories, LLCUpdated: Aug 18, 2026
Eligibility criteria
Male and female patients 18 years of age and older [+3]
History of anaphylactic reactions to products containing indocyanine green for n... [+7]